Panacea
PrivateLast Round
Series B
Extension
Jul 14, 2025
Est. Valuation
$105.26M
Total Funding Raised
$61.5M
Company Overview
Panacea is a healthcare technology company that provides AI-native FDA regulatory services by pairing expert consultants with an AI platform to accelerate the approval process for biotech and medtech companies.
Sector
FinTech
Verticals
Digital Banking, Lending & Credit, Personal Finance
Business Model
B2C
Customer Profile
Payment Processing Fee, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panacea Comparables
Compare Panacea with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Doc2Doc Lending | 83% | |
| Fifth Third Bancorp | 80% | |
| KeyBank | 79% |
Panacea Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 14, 2025 | ||||
| Series B | Jan 16, 2024 |
Panacea Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Valar Ventures | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2025
$37M round led by Valar Ventures.
- Jan 16, 2024
$25M round led by Valar Ventures
Panacea Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Panacea's valuation, stock price, and market status.
Is Panacea a public or private company?
Panacea is a private company.
What is the current stock price of Panacea?
Panacea is a private company with no public stock price. No recent secondary market data is available.
How much is Panacea worth (valuation)?
Panacea's valuation is estimated at $105.3M based on funding round data.
Can I buy Panacea stock?
Panacea shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Panacea's last funding round?
Panacea's most recent funding round was Series B Extension on January 16, 2024.
Who are the main investors in Panacea?
Key investors in Panacea include Valar Ventures.
Will Panacea IPO soon?
No public IPO plans have been announced for Panacea.
How can I track Panacea secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panacea's secondary market activity and sign up for updates.